Pharmacological import-substituting technologies in otorhinolaryngology
https://doi.org/10.21518/2079-701X-2018-20-84-88
Abstract
This article is devoted to the basic principles of pharmacological import-substitution in the current situation, limiting the capabilities of the Russian economy. It provides an analysis on the current import substitution environment in the various segments of the Russian pharmacological market and solutions. The authors present the Russian GMP-manufacturer of generics, which can ensure the pharmaceutical independence of the Russian medicine.
About the Authors
S. V. Ryazantsev
St. Petersburg Research Institute of Ear, Throat, Nose and Speech, Ministry of Health of the Russian Federation, Saint Petersburg
Russian Federation
Russian Federation
I. V. Fanta
St. Petersburg Research Institute of Ear, Throat, Nose and Speech, Ministry of Health of the Russian Federation, Saint Petersburg
Russian Federation
Russian Federation
S. S. Pavlova
St. Petersburg Research Institute of Ear, Throat, Nose and Speech, Ministry of Health of the Russian Federation, Saint Petersburg
Russian Federation
Russian Federation
References
1. Dzanaeva AV, Omelyanovsky VV, Kagermazova S. Principles of pharmacological import substitution. Farmakoehkonomika. Sovremennaya Farmakoehkonomika i Farmakoehpidemiologiya, 2015, 8 (2): 38-42. doi: 10.17749 / 2070-4909.2015.8.2.038-042.
2. Yanov YuK, Ryazantsev SV, Budkovaya MA. Pharmacological import-substituting technologies in otorhinolaryngology. Rossiyskaya Otorinolaringologiya, 2017, 2 (87): 170-176. doi: 10.18692 / 1810-4800-2017-2-170-176.
3. Grigorieva KD. Pharmacological import substitution is a promising direction of development of the Russian economy. Upravlencheskoe Konsultirovanie, 2018, 5: 137-142. doi 10.22394 / 1726-1139-2018-5-137-142.
4. Sidorova IS. Will Russia become independent of imported drugs? Remedium. Zhurnal o Rossiyskom Rynke Lekarstv i Meditsinskoy Tekhnike, 2012, 8: 40-43.
5. Khorunzhaya AA, Savitsky GV. The impact of import substitution on the production of essential and important drugs (VED) in Russia. Almanakh Molodoy Nauki, 2017, 2: 22-26.
6. Tsatsulin AN, Tsatsulin BA. Cluster innovation or import substitution is a development priority of the sectoral economy (as exemplified by the pharmaceutical industry). Nauchno-Tekhnicheskie Vedomosti SPbGPU. Ekonomicheskie Nauki, 2016, 1 (235): 167-181. doi: 10.5862 / JE.235.16.
7. Lapochkin OL, Kagermazova SA. Import substitution of medicinal products and medical devices in Russia: current situation, risks and prospects. Meditsinskie Tekhnologii. Otsenka i Vybor, 2015, 2 (20): 33–36.
8. Kostromin PA. Pharmacological import substitution in Russia in terms of volume, nomenclature and quality. Teoriya i Praktika Obschestvennogo Razvitiya, 2015, 9: 73–77.
Review
For citations:
Ryazantsev SV, Fanta IV, Pavlova SS. Pharmacological import-substituting technologies in otorhinolaryngology. Meditsinskiy sovet = Medical Council. 2018;(20):84-88. (In Russ.) https://doi.org/10.21518/2079-701X-2018-20-84-88
Views:
588
Email this article 